Electromembrane Extraction and Mass Spectrometry for Liver Organoid Drug Metabolism Studies
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- acs.analchem.0c05082
Final published version, 6.42 MB, PDF document
Liver organoids are emerging tools for precision drug development and toxicity screening. We demonstrate that electromembrane extraction (EME) based on electrophoresis across an oil membrane is suited for segregating selected organoid-derived drug metabolites prior to mass spectrometry (MS)-based measurements. EME allowed drugs and drug metabolites to be separated from cell medium components (albumin, etc.) that could interfere with subsequent measurements. Multiwell EME (parallel-EME) holding 100 μL solutions allowed for simple and repeatable monitoring of heroin phase I metabolism kinetics. Organoid parallel-EME extracts were compatible with ultrahigh-performance liquid chromatography (UHPLC) used to separate the analytes prior to detection. Taken together, liver organoids are well-matched with EME followed by MS-based measurements.
Original language | English |
---|---|
Journal | Analytical Chemistry |
Volume | 93 |
Issue number | 7 |
Pages (from-to) | 3576-3585 |
Number of pages | 10 |
ISSN | 0003-2700 |
DOIs | |
Publication status | Published - 2021 |
Number of downloads are based on statistics from Google Scholar and www.ku.dk
ID: 259881409